Synthetic biology-driven optimization of microbial natural product synthesis involves genetically engineering microbial cell factories via gene editing, metabolic engineering, and modular design to enhance the yield and diversity of natural products (e.g., antibiotics, anti-inflammatory drugs). This field integrates rational design and automated platforms to accelerate drug discovery and green biomanufacturing, offering sustainable solutions for medicine, agriculture, and beyond.